BioCentury
ARTICLE | Company News

Draxis receives FDA approval

August 24, 2000 7:00 AM UTC

The FDA granted marketing approval to DRAX's Draximage Inc. subsidiary (Kirkland, Quebec) for its BrachySeed iodine-125 brachytherapy seed product to treat prostate cancer. BrachySeed received Canadia...